M&As this week: Hildred Capital Partners, Novartis, Neos Therapeutics
Private investment firm Hildred Capital Partners plans to acquire a majority stake in pharmaceutical company Crown Laboratories. Both companies involved…
Private investment firm Hildred Capital Partners plans to acquire a majority stake in pharmaceutical company Crown Laboratories. Both companies involved…
Chinese pharmaceutical products manufacturer Xiangxue Pharmaceutical has raised CNY600m ($90.23m) through a public offering of corporate bonds. Sumitomo Dainippon Pharma…
Indonesia’s pharmaceutical market is projected to reach $10.11bn by 2021, according to a report by GlobalData. Titled ‘CountryFocus: Healthcare, Regulatory…
Chinese pharmaceutical company WuXi AppTec plans to acquire US-based contract research organisation (CRO) ResearchPoint Global (RPG). RPG will become WuXi AppTec’s…
Chinese pharmaceutical company Harbin Gloria Pharmaceuticals intends to issue medium-term notes due 2019 in a public offering to raise CNY1.6bn…
The global Alzheimer’s disease (AD) market is expected to increase from $2.9bn in 2016 to $14.8bn, rising at a compound…
US-based pharmaceutical company Catalent Pharma Solutions plans to raise $450m through the private placement of senior unsecured notes, due 2026.…
US-based pharmaceutical company Catalent Pharma Solutions plans to raise $450m through the private placement of senior unsecured notes, due 2026.…
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Adcetris (brentuximab vedotin) in combination with chemotherapy…
Transgene has a partnered with in-vitro diagnostics company Randox to combine their technologies and develop multifunctional oncolytic immunotherapies. New oncolytic…